AdopTracell is a biotech/pharmaceutical start-up company based upon patented foundational technologies. This university spinoff company primarily focuses on development of chimeric antigen receptor (CAR) regulatory T cells (Treg) capable of recognizing relevant human autoantigens resulting in effector T cell (Teff)...